Xconomy | San Diego - Business + Technology in the Exponential Economy

Wireless Medicine Gets $45M Booster Shot, Arena’s Weight-Loss Trial Underwhelms Wall Street, Venter’s Synthetic Genomics About to Ramp Up, & Other San Diego BizTech News
Ambrx Gets $10 Million in Venture Round
Exact Sciences Makes the List, Curis and Alkermes Get Dropped, Patent Reform Sparks Debate, & More Life Sciences News
Alnylam Chief Foresees Another Gene-Silencing Spin-Off, and More News Tidbits from Boston’s MassBio Investors Forum
Alnylam Eyes RNAi for Manufacturing Drugs

Traversa Gets $5M

San Diego-based Traversa Therapeutics today announced it has raised $5 million in a Series B financing round; Morningside Venture Investments led the deal, which was joined by Mesa Verde Venture Partners and existing investors. The company says the money will help it move its RNAi-based treatments for cancer into clinical trials. Founded in mid-2006, Traversa previously raised $2 million in a round led by San Diego Tech Coast Angels.

Comments | Reprints | Share: